跳至主要内容
临床试验/NCT06479434
NCT06479434已完成不适用

Association of Serum Biomarkers in Polycystic Ovarian Syndrome (PCOS) Females With and Without Metformin Versus Healthy Controls

Aga Khan University1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2024年6月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
110
试验地点
1
主要终点
Change in hormonal profile and menstural Cycle after Metformin use

研究概览

简要总结

The goal of this interventional study is to assess the effect of drug metformin in improving the fertility hormones and reducing the inflammatory hormones in polycystic ovarian syndrome (PCOS) patients. We wish to answer the question whether metformin is necessary to improve PCOS symptoms versus simple lifestyle modification.

Participants once diagnosed with PCOS will be given metformin to be sued for 8 weeks. They will be asked to provide blood samples on day 0 and after 8 weeks of metformin use. The blood sample will be used to measure the hormonal and inflammatory profile. In addition, they will be required to compete a questionnaire regarding symptoms such as decrease in facial hair growth, improvement in menstrual cycle etc.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • a) Patients Falling into PCOS as per Rotterdam criteria

排除标准

  • Systemic diseases like atherosclerosis,
  • Diabetes mellitus
  • Hypertension
  • congenital adrenal hyperplasia, androgen secreting tumors

研究组 & 干预措施

Metformin Treated PCO

Experimental

After taking informed consent demographic data like name, age, anthropometric measurements (blood pressure, BMI, weight, height)will be recorded by researcher Body mass index (BMI), waist circumference, waist to hip ratio will be evaluated. Blood samples will be collected after an overnight fast of 8 to 10 hours. Then metformin will be given to subjects a dose of 500 mg three times a day for 8 weeks. Serum biomarkers and inflammatory markers will be assessed at day 0 and after 8 weeks post metformin administration.

干预措施: Metformin (Drug)

结局指标

主要结局

Change in hormonal profile and menstural Cycle after Metformin use

时间窗: 8 weeks

Serum reproductory hormone levels (follicle stimulating hormone, testosterone), inflammatory hormones (tumor necrosis factor, c reactive protein) will be measured at day 0 and after 8 weeks of intervention

次要结局

  • Change in symptoms associated with PCO after intervention(8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sadia Fatima

Associate Professor

Aga Khan University

研究点 (1)

Loading locations...

相似试验